{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:28:07Z","timestamp":1793953687390,"version":"4.8.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2018ZX10722301-003"],"award-info":[{"award-number":["2018ZX10722301-003"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Shanghai Municipality Science and Technology Commission","doi-asserted-by":"publisher","award":["GWVI-11.2-YQ03"],"award-info":[{"award-number":["GWVI-11.2-YQ03"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Shanghai Municipality Science and Technology Commission","doi-asserted-by":"publisher","award":["HS2021SHZX001"],"award-info":[{"award-number":["HS2021SHZX001"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014137","name":"Shanghai Shenkang Hospital Development Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014137","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008750","name":"Shanghai Shenkang Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC2020CR1011B"],"award-info":[{"award-number":["SHDC2020CR1011B"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijid.2026.108661","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:35:44Z","timestamp":1775057744000},"page":"108661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["QT interval prolongation and cardiotoxicity in shorter regimens for rifampicin-resistant tuberculosis"],"prefix":"10.1016","volume":"167","author":[{"given":"Yilin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengzhong","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanbo","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jichan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yungui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingying","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zebao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yena","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2026.108661_bib0001","series-title":"Global tuberculosis report 2025","year":"2025"},{"key":"10.1016\/j.ijid.2026.108661_bib0002","article-title":"Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses","volume":"50","author":"Khan","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2026.108661_bib0003","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jacc.2006.08.058","article-title":"The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias","volume":"49","author":"Topilski","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijid.2026.108661_bib0004","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1053\/euhj.1998.1094","article-title":"The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens","volume":"19","author":"Elming","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijid.2026.108661_bib0005","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1183\/13993003.01552-2016","article-title":"Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine","volume":"48","author":"Tadolini","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2026.108661_bib0006","first-page":"122","article-title":"Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG","volume":"59","author":"Kang","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.ijid.2026.108661_bib0007","series-title":"WHO consolidated guidelines on tuberculosis: module 4: treatment and care","year":"2025"},{"key":"10.1016\/j.ijid.2026.108661_bib0008","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1164\/rccm.v201erratum2","article-title":"Treatment of drug-resistant tuberculosis. An Official ATS\/CDC\/ERS\/IDSA Clinical Practice Guideline (vol 200, pg e93, 2019)","volume":"201","author":"Nahid","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2026.108661_bib0009","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa1811867","article-title":"A trial of a shorter regimen for rifampin-resistant tuberculosis","volume":"380","author":"Nunn","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2026.108661_bib0010","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJMoa2400327","article-title":"Oral regimens for rifampin-resistant, fluoroquinolone-susceptible tuberculosis","volume":"392","author":"Guglielmetti","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2026.108661_bib0011","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cmi.2025.11.015","article-title":"A 6- to 9-months oral regimen for rifampicin-resistant tuberculosis: a randomized open-label noninferiority trial in China","volume":"32","author":"Sun","year":"2025","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2026.108661_bib0012","doi-asserted-by":"crossref","first-page":"e502","DOI":"10.1093\/cid\/ciaf351","article-title":"A short, all-oral regimen for preextensively drug-resistant tuberculosis: a multicenter open-label single-arm study","volume":"81","author":"Li","year":"2026","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.108661_bib0013","series-title":"Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis","year":"2014"},{"key":"10.1016\/j.ijid.2026.108661_bib0014","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/S0140-6736(22)02078-5","article-title":"Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (Stream stage 2): an open-label, multicentre, randomised, non-inferiority trial","volume":"400","author":"Goodall","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2026.108661_bib0015","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S2213-2600(25)00194-8","article-title":"Bedaquiline, delamanid, linezolid, and clofazimine for rifampicin-resistant and fluoroquinolone-resistant tuberculosis (endTB-Q): an open-label, multicentre, stratified, non-inferiority, randomised, controlled, phase 3 trial","volume":"13","author":"Guglielmetti","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ijid.2026.108661_bib0016","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1056\/NEJMoa2117166","article-title":"A 24-week, all-oral regimen for rifampin-resistant tuberculosis","volume":"387","author":"Nyang'wa","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2026.108661_bib0017","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2213-2600(23)00389-2","article-title":"Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial","volume":"12","author":"Nyang'wa","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ijid.2026.108661_bib0018","series-title":"medRxiv","article-title":"BEAT tuberculosis: a randomized controlled trial of a 6-month strategy for rifampicin-resistant tuberculosis","author":"Conradie","year":"2025"},{"key":"10.1016\/j.ijid.2026.108661_bib0019","doi-asserted-by":"crossref","first-page":"ofab413","DOI":"10.1093\/ofid\/ofab413","article-title":"QT interval prolongation in people treated with bedaquiline for drug-resistant tuberculosis under programmatic conditions: a retrospective cohort study","volume":"8","author":"Isralls","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijid.2026.108661_bib0020","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/cid\/ciab335","article-title":"Effectiveness and cardiac safety of bedaquiline-based therapy for drug-resistant tuberculosis: a prospective cohort study","volume":"73","author":"Brust","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.108661_bib0021","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00536-24","article-title":"How much should we still worry about QTc prolongation in rifampicin-resistant tuberculosis? ECG findings from TB-PRACTECAL clinical trial","volume":"68","author":"Motta","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2026.108661_bib0022","series-title":"WHO operational handbook on tuberculosis: module 4: treatment: drug-resistant tuberculosis treatment","year":"2022"},{"key":"10.1016\/j.ijid.2026.108661_bib0023","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMra032426","article-title":"Drug-induced prolongation of the QT interval","volume":"350","author":"Roden","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2026.108661_bib0024","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1086\/508873","article-title":"Antimicrobial-associated QT interval prolongation: pointes of interest","volume":"43","author":"Owens","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.108661_bib0025","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ahj.2007.01.040","article-title":"Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes","volume":"153","author":"Gupta","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijid.2026.108661_bib0026","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jacc.2015.12.063","article-title":"Predicting the unpredictable: drug-induced QT prolongation and torsades de pointes","volume":"67","author":"Schwartz","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijid.2026.108661_bib0027","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1128\/JCM.01780-07","article-title":"Cavitary disease and quantitative sputum bacillary load in cases of pulmonary tuberculosis","volume":"45","author":"Palaci","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2026.108661_bib0028","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/cid\/cir904","article-title":"Additional drug resistance in Mycobacterium tuberculosis isolates from resected cavities among patients with multidrug-resistant or extensively drug-resistant pulmonary tuberculosis","volume":"54","author":"Kempker","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.108661_bib0029","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0140-6736(02)09742-8","article-title":"Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial","volume":"360","author":"Benator","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2026.108661_bib0030","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1016\/S1473-3099(20)30148-1","article-title":"Cavitary tuberculosis: the gateway of disease transmission","volume":"20","author":"Urbanowski","year":"2020","journal-title":"Lancet Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226002961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226002961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:04:28Z","timestamp":1793952268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226002961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":30,"alternative-id":["S1201971226002961"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108661","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"QT interval prolongation and cardiotoxicity in shorter regimens for rifampicin-resistant tuberculosis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108661","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108661"}}